Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali

[1]  S. Cousens,et al.  Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Burkina Faso: A Randomised, Double-Blind, Placebo-Controlled Trial , 2011, PLoS medicine.

[2]  C. Long,et al.  Immunogenicity of Self-Associated Aggregates and Chemically Cross-Linked Conjugates of the 42 kDa Plasmodium falciparum Merozoite Surface Protein-1 , 2012, PloS one.

[3]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[4]  M. Fay,et al.  Phase 1 Study of Two Merozoite Surface Protein 1 (MSP142) Vaccines for Plasmodium falciparum Malaria , 2007, PLoS clinical trials.

[5]  Virander S. Chauhan,et al.  Impact of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine on Antibody Responses to Erythrocytic-Stage Plasmodium falciparum Antigens in Infants in Mozambique , 2008, Clinical and Vaccine Immunology.

[6]  B. Cissé,et al.  Potential Impact of Seasonal Malaria Chemoprevention on the Acquisition of Antibodies against Glutamate-Rich Protein and Apical Membrane Antigen 1 in Children Living in Southern Senegal , 2015, American Journal of Tropical Medicine and Hygiene.

[7]  J. Cox,et al.  Combined DNA extraction and antibody elution from filter papers for the assessment of malaria transmission intensity in epidemiological studies , 2013, Malaria Journal.

[8]  O. Toure,et al.  Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali , 2008, Malaria Journal.

[9]  M. Feeney,et al.  Effective Antimalarial Chemoprevention in Childhood Enhances the Quality of CD4+ T Cells and Limits Their Production of Immunoregulatory Interleukin 10. , 2016, The Journal of infectious diseases.

[10]  A. Dicko,et al.  Effect of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali , 2017, Malaria Journal.

[11]  B. Cissé,et al.  Immunological consequences of intermittent preventive treatment against malaria in Senegalese preschool children , 2010, Malaria Journal.

[12]  A. Dicko,et al.  Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial , 2018, PloS one.

[13]  P. Byass,et al.  Cellular immune responses to Plasmodium falciparum antigens in children receiving long term anti-malarial chemoprophylaxis. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[14]  P. Rosenthal,et al.  Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial , 2019, Malaria Journal.

[15]  Paul Milligan,et al.  Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial , 2016, PLoS medicine.

[16]  A. Jin,et al.  Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine Candidate* , 2009, The Journal of Biological Chemistry.